Geode Capital Management, LLC Cerus Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cerus Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,415,453 shares of CERS stock, worth $7.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,415,453
Previous 4,345,503 1.61%
Holding current value
$7.59 Million
Previous $7.65 Million 0.44%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$1.7 - $2.39 $118,915 - $167,180
69,950 Added 1.61%
4,415,453 $7.68 Million
Q2 2024

Aug 09, 2024
BUY
$1.62 - $2.04 $296,719 - $373,646
183,160 Added 4.4%
4,345,503 $7.65 Million
Q1 2024

May 13, 2024
BUY
$1.66 - $2.42 $248,374 - $362,087
149,623 Added 3.73%
4,162,343 $7.87 Million
Q4 2023

Feb 13, 2024
BUY
$1.25 - $2.35 $303,653 - $570,869
242,923 Added 6.44%
4,012,720 $8.67 Million
Q3 2023

Nov 13, 2023
BUY
$1.5 - $3.07 $373,426 - $764,279
248,951 Added 7.07%
3,769,797 $6.11 Million
Q2 2023

Aug 11, 2023
BUY
$1.79 - $2.9 $240,601 - $389,800
134,414 Added 3.97%
3,520,846 $8.66 Million
Q1 2023

May 15, 2023
BUY
$2.65 - $3.81 $422,463 - $607,390
159,420 Added 4.94%
3,386,432 $10.1 Million
Q4 2022

Feb 13, 2023
BUY
$3.38 - $4.22 $272,117 - $339,743
80,508 Added 2.56%
3,227,012 $11.8 Million
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $343,607 - $584,031
100,177 Added 3.29%
3,146,504 $11.3 Million
Q2 2022

Aug 12, 2022
SELL
$4.41 - $5.69 $417,649 - $538,871
-94,705 Reduced 3.02%
3,046,327 $16.1 Million
Q1 2022

May 13, 2022
SELL
$4.81 - $6.99 $1.07 Million - $1.56 Million
-223,118 Reduced 6.63%
3,141,032 $17.2 Million
Q4 2021

Feb 11, 2022
BUY
$5.97 - $7.93 $876,975 - $1.16 Million
146,897 Added 4.57%
3,364,150 $22.9 Million
Q3 2021

Nov 12, 2021
BUY
$4.79 - $6.68 $1.01 Million - $1.41 Million
210,867 Added 7.01%
3,217,253 $19.6 Million
Q2 2021

Aug 13, 2021
BUY
$5.35 - $6.35 $496,228 - $588,981
92,753 Added 3.18%
3,006,386 $17.8 Million
Q1 2021

May 12, 2021
BUY
$5.68 - $7.87 $1.4 Million - $1.94 Million
246,545 Added 9.24%
2,913,633 $17.5 Million
Q4 2020

Feb 12, 2021
BUY
$5.25 - $8.56 $606,432 - $988,774
115,511 Added 4.53%
2,667,088 $18.5 Million
Q3 2020

Nov 13, 2020
BUY
$5.78 - $7.47 $206,877 - $267,366
35,792 Added 1.42%
2,551,577 $16 Million
Q2 2020

Aug 13, 2020
BUY
$4.5 - $7.02 $701,955 - $1.1 Million
155,990 Added 6.61%
2,515,785 $16.6 Million
Q1 2020

May 14, 2020
BUY
$2.87 - $5.49 $1.31 Million - $2.51 Million
457,396 Added 24.04%
2,359,795 $11 Million
Q4 2019

Feb 13, 2020
BUY
$3.84 - $4.86 $221,556 - $280,407
57,697 Added 3.13%
1,902,399 $8.03 Million
Q3 2019

Nov 12, 2019
BUY
$4.86 - $6.05 $220,250 - $274,179
45,319 Added 2.52%
1,844,702 $9.51 Million
Q2 2019

Aug 14, 2019
BUY
$4.51 - $6.6 $540,248 - $790,607
119,789 Added 7.13%
1,799,383 $10.1 Million
Q1 2019

May 14, 2019
BUY
$5.16 - $6.85 $843,670 - $1.12 Million
163,502 Added 10.78%
1,679,594 $10.5 Million
Q4 2018

Feb 13, 2019
BUY
$4.89 - $7.16 $383,380 - $561,351
78,401 Added 5.45%
1,516,092 $7.69 Million
Q3 2018

Nov 13, 2018
BUY
$6.89 - $7.78 $525,080 - $592,906
76,209 Added 5.6%
1,437,691 $10.4 Million
Q2 2018

Aug 14, 2018
BUY
$5.19 - $7.25 $1.25 Million - $1.75 Million
241,321 Added 21.54%
1,361,482 $9.08 Million
Q1 2018

May 15, 2018
BUY
$3.56 - $5.74 $462,219 - $745,264
129,837 Added 13.11%
1,120,161 $6.14 Million
Q4 2017

Feb 13, 2018
BUY
$2.76 - $3.95 $211,393 - $302,538
76,592 Added 8.38%
990,324 $3.35 Million
Q3 2017

Nov 14, 2017
SELL
$2.22 - $2.73 $905 - $1,113
-408 Reduced 0.04%
913,732 $2.49 Million
Q2 2017

Aug 14, 2017
BUY
N/A
914,140
914,140 $2.29 Million

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $305M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email